A longitudinal study of abnormalities on MRI and disability from multiple sclerosis

Brex, Peter A., Ciccarelli, Olga, O'Riordan, Jonathon I., Sailer, Michael, Thompson, Alan J., Miller, David H.·2002·New England Journal of Medicine
DOI 10.1056/nejmoa011341

Cited by (858)

Items 101–200 of 858

  1. Adherence to disease-modifying therapies and its impact on relapse, health resource utilization, and costs among patients with multiple sclerosis
    JACK S. BURKS, Thomas Marshall, Xiaolan Ye · 2017 · ClinicoEconomics and Outcomes Research
  2. Prediction of disease progression and outcomes in multiple sclerosis with machine learning
    Mauro F. Pinto, Hugo Oliveira, Sónia Batista, Luís Cruz, Mafalda Pinto, Inês Correia, Pedro Martins, César Teixeira · 2020 · Scientific Reports
  3. Cerebrospinal fluid biomarkers in multiple sclerosis
    Hayrettin Tumani, Hans‐Peter Hartung, Bernhard Hemmer, Charlotte Elisabeth Teunissen, Florian Deisenhammer, Gavin Giovannoni, Uwe Klaus Zettl · 2009 · Neurobiology of Disease
  4. The Natural History of Recurrent Optic Neuritis
    Istvan Pirko, Lori K. Blauwet, Timothy G. Lesnick, Brian G. Weinshenker · 2004 · Archives of Neurology
  5. Early abnormalities of evoked potentials and future disability in patients with multiple sclerosis
    Boris A. Kallmann, S Fackelmann, Klaus Victor Toyka, P Rieckmann, Karlheinz Reiners · 2005 · Multiple Sclerosis Journal
  6. Predictors of long–term clinical response to interferon beta therapy in relapsing multiple sclerosis
    Valentina Tomassini, Andrea Paolillo, Pierluigi Russo, Elisabetta Giugni, Luca Prosperini, Claudio Gasperini, Guido Antonelli, Stefano Bastianello, Carlo Pozzilli · 2005 · Journal of Neurology
  7. MR Imaging in Multiple Sclerosis: Review and Recommendations for Current Practice
    Karl‐Olof Lövblad, Nicoletta Anzalone, Arnd Dörfler, Marco Essig, Barrie J. Hurwitz, Ludwig Kappos, Seung‐Koo Lee, Massimo Filippi · 2009 · American Journal of Neuroradiology
  8. Surrogate endpoints for EDSS worsening in multiple sclerosis
    Maria Pia Sormani, Laura Bonzano, Luca Roccatagliata, Gianluigi Mancardi, Antonio Uccelli, Paolo Bruzzi · 2010 · Neurology
  9. Magnetic resonance imaging measures of brain atrophy in multiple sclerosis
    V. Anderson, Nick C Fox, David H. Miller · 2006 · Journal of Magnetic Resonance Imaging
  10. Relationship between MRI lesion activity and response to IFN-β in relapsing–remitting multiple sclerosis patients
    Jordi Río, Àlex Rovira, Mar Tintoré, Elena Charro Huerga, Carlos Nos, Neus Téllez, Carmen Tur, Manuel Comabella, Xavier Montalbán · 2008 · Multiple Sclerosis Journal
  11. Short-term accrual of gray matter pathology in patients with progressive multiple sclerosis: an in vivo study using diffusion tensor MRI
    Marco Rovaris, Antonio Gallo, Paola Valsasina, Béatrice Benedetti, Domenico Caputo, Angelo Ghezzi, Enrico Montanari, Maria Pia Sormani, Antonio Bertolotto, Gianluigi Mancardi et al. · 2004 · NeuroImage
  12. Assessing structure and function of the afferent visual pathway in multiple sclerosis and associated optic neuritis
    Madhan Kolappan, A. P. D. Henderson, Thomas Michael Jenkins, Claudia A. M. Gandini Wheeler‐Kingshott, Gordon Terence Plant, Alan J. Thompson, DH Miller · 2009 · Journal of Neurology
  13. Abrogation of T cell quiescence characterizes patients at high risk for multiple sclerosis after the initial neurological event
    J. Corvol, D. Pelletier, R. Henry, S. Caillier, Joanne H. Wang, D. Pappas, Simona Casazza, D. Okuda, S. Hauser, J. Oksenberg et al. · 2008 · Proceedings of the National Academy of Sciences of the United States of America
  14. Imaging of multiple sclerosis: Role in neurotherapeutics
    Rohit Bakshi, Alireza Minagar, Zeenat Jaisani, Jerry S. Wolinsky · 2005 · NeuroRx
  15. Magnetization transfer histograms in clinically isolated syndromes suggestive of multiple sclerosis.
    K. Fernando, D. Tozer, K. Miszkiel, R. Gordon, J. Swanton, C. Dalton, G. Barker, G. Plant, A. Thompson, David H. Miller · 2005 · Brain : a journal of neurology
  16. Increased PK11195-PET binding in normal-appearing white matter in clinically isolated syndrome
    Paolo Giannetti, Marios Politis, Paul Su, Federico Turkheimer, Omar Malik, Shiva Keihaninejad A, Kit Wu, Adam D. Waldman, Richard Reynolds, Richard S. Nicholas et al. · 2014 · Brain
  17. Cuprizone treatment induces demyelination and astrocytosis in the mouse hippocampus
    Norkute, Akvile, Hieble, Andrea, Braun, Alena, Johann, Sonja, Clarner, Tim, Baumgartner, Werner, Beyer, Cordian, Kipp, Markus · 2009 · Journal of Neuroscience Research
  18. Functional Brain Reorganization in Multiple Sclerosis: Evidence from fMRI Studies
    Patrizià Pantano, Caterina Mainero, Francesca Caramia · 2006 · Journal of Neuroimaging
  19. Diffusion-tensor magnetic resonance imaging detects normal-appearing white matter damage unrelated to short-term disease activity in patients at the earliest clinical stage of multiple sclerosis.
    A. Gallo, M. Rovaris, R. Riva, A. Ghezzi, B. Benedetti, V. Martinelli, A. Falini, G. Comi, M. Filippi · 2005 · Archives of Neurology
  20. Cognitive impairment in multiple sclerosis can be predicted by imaging early in the disease
    Mary Summers, Josephine K. Swanton, Kryshani Fernando, Catherine M. Dalton, DH Miller, Lisa Cipolotti A, María A. Ron · 2008 · Journal of Neurology Neurosurgery & Psychiatry
  21. Sensitivity of multi-shell NODDI to multiple sclerosis white matter changes: a pilot study
    Schneider, Torben · 2017 · Functional Neurology
  22. Chronic Progressive Multiple Sclerosis – Pathogenesis of Neurodegeneration and Therapeutic Strategies
    D. Fitzner, M. Simons · 2010 · Current Neuropharmacology
  23. Biomarkers in Multiple Sclerosis: An Up-to-Date Overview
    Serafeim Katsavos, Maria C. Anagnostouli · 2013 · Multiple Sclerosis International
  24. Treatment Optimization in Multiple Sclerosis
    Mark Steven Freedman, David G. Patry, François Grand’Maison, Mary Lou Myles, Donald W. Paty, Daniel H. Selchen · 2004 · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
  25. Clinical features and diagnosis of multiple sclerosis.
    F. Lublin · 2005 · Neurologic clinics
  26. A 30‐Year Clinical and Magnetic Resonance Imaging Observational Study of Multiple Sclerosis and Clinically Isolated Syndromes
    Karen K. Chung, Daniel R. Altmann, Frederik Barkhof, Katherine Miszkiel, Peter Brex, J. I. O’Riordan, Michael Ebner, Ferrán Prados, M. Jorge Cardoso, Tom K. Vercauteren et al. · 2019 · Annals of Neurology
  27. Neuroradiological evaluation of demyelinating disease
    Jan‐Mendelt Tillema, Istvan Pirko · 2013 · Therapeutic Advances in Neurological Disorders
  28. Simple and complex movement‐associated functional MRI changes in patients at presentation with clinically isolated syndromes suggestive of multiple sclerosis
    Massimo Filippi, Maria Assunta Rocca, Domenico Maria Mezzapesa, Angelo Ghezzi, Andrea Falini, Vittorio Martinelli, Giuseppe Scotti, Giancarlo Comi · 2003 · Human Brain Mapping
  29. Evolving expectations around early management of multiple sclerosis
    R. Gold, J. Wolinsky, M. Amato, G. Comi · 2010 · Therapeutic Advances in Neurological Disorders
  30. Full results of the Evidence of Interferon Dose-Response-European North American Comparative Efficacy (EVIDENCE) study: A multicenter, randomized, assessor-blinded comparison of low-dose weekly versus high-dose, high-frequency interferon β-1a for relapsing multiple sclerosis
    Steven Schwid, HILLEL S. PANITCH · 2007 · Clinical Therapeutics
  31. Pre-specified subgroup analyses of a placebo-controlled phase III trial (TEMSO) of oral teriflunomide in relapsing multiple sclerosis
    Aaron Miller, Paul W O'Connor, Jerry S. Wolinsky, Christian Confavreux, Ludwig Kappos, Tomas P Olsson, Philippe Truffinet, Lin Wang, Laura D’Castro, Gıancarlo Comı et al. · 2012 · Multiple Sclerosis Journal
  32. MR in the diagnosis and monitoring of multiple sclerosis: An overview
    Àlex Rovira, Adelaida León · 2008 · European Journal of Radiology
  33. The longitudinal relation between brain lesion load and atrophy in multiple sclerosis: a 14 year follow up study
    Declan Chard · 2003 · Journal of Neurology Neurosurgery & Psychiatry
  34. Acute disseminated encephalomyelitis: Treatment guidelines
    Myriam Alexander, Jagarlapudi M. K. Murthy · 2011 · Annals of Indian Academy of Neurology
  35. Reliability of Classifying Multiple Sclerosis Disease Activity Using Magnetic Resonance Imaging in a Multiple Sclerosis Clinic
    Ebru Erbayat Altay, Elizabeth Fisher, Stephen E. Jones, Claire Hara-Cleaver, Jar-Chi Lee, Richard A. Rudick · 2012 · JAMA Neurology
  36. Early MRI in optic neuritis: The risk for disability
    Swanton, J. K., Fernando, K. T., Dalton, C. M., Miszkiel, K. A., Altmann, D. R., Plant, G. T., Thompson, A. J., Miller, D. H. · 2009 · Neurology
  37. MRI in Multiple Sclerosis: What’s Inside the Toolbox?
    Mohit Neema, James Stankiewicz, Ashish Arora, Zachary David Guss, Rohit Bakshi · 2007 · Neurotherapeutics
  38. Fingolimod versus intramuscular interferon in patient subgroups from TRANSFORMS
    Jeffrey A. Cohen, Frederik Barkhof, Gıancarlo Comı, Guillermo Izquierdo, Bhupendra Odhavji Khatri, Xavier Montalbán, Jean Pelletier, Benjamin J. Eckert, Dieter Adrian Häring, Gordon Francis · 2013 · Journal of Neurology
  39. Brain atrophy and lesion load measures over 1 year relate to clinical status after 6 years in patients with clinically isolated syndromes
    Massimiliano Di Filippo, Valerie M. Anderson, Daniel R. Altmann, Josephine K. Swanton, Gordon Terence Plant, Alan J. Thompson, DH Miller · 2009 · Journal of Neurology Neurosurgery & Psychiatry
  40. Multiple sclerosis diagnostic criteria: three years later
    Chris H. Polman, Jerry S. Wolinsky, Stephen C. Reingold · 2005 · Multiple Sclerosis Journal
  41. Effect of changes in MS diagnostic criteria over 25 years on time to treatment and prognosis in patients with clinically isolated syndrome
    Tintore, Mar, Cobo-Calvo, Alvaro, Carbonell, Pere, Arrambide, Georgina, Otero-Romero, Susana, Río, Jordi, Tur, Carmen, Comabella, Manuel, Nos, Carlos, Arévalo, María Jesús et al. · 2021 · Neurology
  42. Role of magnetic resonance imaging within diagnostic criteria for multiple sclerosis
    David H. Miller, Massimo Filippi, Franz Fazekas, Jette Lautrup Frederiksen, Paul McMahan Matthews, Xavier Montalbán, Chris H. Polman · 2004 · Annals of Neurology
  43. Quantification and clinical relevance of brain atrophy in multiple sclerosis: a review
    B. Grassiot, B. Desgranges, F. Eustache, G. Defer · 2009 · Journal of Neurology
  44. Role of MRI in multiple sclerosis I: inflammation and lesions
    Robert Zivadinov · 2004 · Frontiers in bioscience
  45. Campath-1H treatment of multiple sclerosis: lessons from the bedside for the bench
    Alasdair J. Coles, Jackie Deans, Alastair Compston · 2004 · Clinical Neurology and Neurosurgery
  46. Review: Treatment of early multiple sclerosis: the value of treatment initiation after a first clinical episode
    DS Goodin, D. Bates · 2009 · Multiple Sclerosis Journal
  47. Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing–remitting multiple sclerosis: subgroup analyses of the CONFIRM study
    Michael Hutchinson, Robert James Fox, David H. Miller, J. Theodore Phillips, Mariko Kita, Eva Havrdová, John T. O'Gorman, Ray Zhang, Mark Novas, Vissia Viglietta et al. · 2013 · Journal of Neurology
  48. Central Nervous System Atrophy and Clinical Status in Multiple Sclerosis
    Robert Zivadinov, Rohit Bakshi · 2004 · Journal of Neuroimaging
  49. Volumetric MRI Markers and Predictors of Disease Activity in Early Multiple Sclerosis: A Longitudinal Cohort Study
    Tomáš Kalinčík, Manuela Vaněčková, Michaela Týblová, Jan Krásenský, Zdeněk Seidl, Eva Havrdová, Dana Horáková · 2012 · PLoS ONE
  50. Remyelination Therapy in Multiple Sclerosis
    Danielle E. Harlow, Justin Morris Honce, Augusto A. Miravalle · 2015 · Frontiers in Neurology
  51. Clinical, MRI, and CSF Markers of Disability Progression in Multiple Sclerosis
    Alberto Gajofatto, Massimiliano Calabrese, Maria Donata Benedetti, Salvatore Monaco · 2013 · Disease Markers
  52. Cerebrospinal fluid detection of interleukin-1β in phase of remission predicts disease progression in multiple sclerosis
    S. Rossi, V. Studer, C. Motta, Giorgio Germani, Giulia Macchiarulo, F. Buttari, R. Mancino, Maura Castelli, V. De Chiara, Sagit Weiss et al. · 2014 · Journal of Neuroinflammation
  53. Accuracy of magnetic resonance imaging for the diagnosis of multiple sclerosis: systematic review
    Penny F. Whiting, Roger M. Harbord, Caroline Main, Jonathan James Deeks, Graziella Filippini, Matthias Egger, Jonathan A C Sterne · 2006 · BMJ
  54. What affects your MS? Responses to an anonymous, Internet-based epidemiological survey
    Rex D. Simmons, Anne‐Louise Ponsonby, Ingrid A.F. van der Mei, Peter M. Sheridan · 2004 · Multiple Sclerosis Journal
  55. Most Patients With Multiple Sclerosis or a Clinically Isolated Demyelinating Syndrome Should Be Treated at the Time of Diagnosis
    Elliot M. Frohman, Eva Havrdová, FRED D. LUBLIN, Frederik Barkhof, Anat Achiron, M. K. Sharief, Olaf Stüve, Michael K. Racke, Lawrence Steinman, Howard L. Weiner et al. · 2006 · Archives of Neurology
  56. Neurologic Impairment 10 Years After Optic Neuritis
    Optic Neuritis Study Group · 2004 · Archives of Neurology
  57. Predicting outcome in clinically isolated syndrome using machine learning
    Viktor Wottschel, Daniel C. Alexander, PP Kwok, Declan Chard, Maria Laura Stromillo, Nicola De Stefano, Alan J. Thompson, David H. Miller, Olga Ciccarelli · 2014 · NeuroImage Clinical
  58. Neuroimaging In Multiple Sclerosis
    Robert Zivadinov, Jennifer L. Cox · 2007 · International review of neurobiology
  59. Progressive solitary sclerosis: Gradual motor impairment from a single CNS demyelinating lesion
    Keegan, B. Mark, Kaufmann, Timothy J., Weinshenker, Brian G., Kantarci, Orhun H., Schmalstieg, William F., Paz Soldan, M. Mateo, Flanagan, Eoin P. · 2016 · Neurology
  60. Normal-appearing brain tissue MTR histograms in clinically isolated syndromes suggestive of MS
    Anthony L. Traboulsee, Jamshid Dehmeshki, Peter Brex, Catherine M. Dalton, Declan Chard, Gareth J. Barker, Gordon Terence Plant, DH Miller · 2002 · Neurology
  61. Diagnostic value of alternative techniques to gadolinium-based contrast agents in MR neuroimaging—a comprehensive overview
    Anna Falk Delgado, Danielle van Westen, Markus Nilsson, Linda Knutsson, Pia C. Sundgren, Elna‐Marie Larsson, Alberto Falk Delgado · 2019 · Insights into Imaging
  62. The long-term outcomes of CIS patients in the Barcelona inception cohort: Looking back to recognize aggressive MS
    Mar Tintoré, Georgina Arrambide, Susana Otero‐Romero, Pere Carbonell‐Mirabent, Jordi Río, Carmen Tur, Manuel Comabella, Carlos Nos, María Jesús Arévalo, Elisenda Anglada et al. · 2019 · Multiple Sclerosis Journal
  63. Lesion distribution in children with clinically isolated syndromes
    Rezwan Ghassemi, Samson B. Antel, Sridar Narayanan, Simon J. Francis, Amit Bar‐Or, Adele Dessa Sadovnick, Brenda Banwell, Douglas Lorne Arnold, Canadian Pediatric Demyelinating Disease Study Group · 2008 · Annals of Neurology
  64. Disease-associated inflammatory biomarker profiles in blood in different subtypes of multiple sclerosis: Prospective clinical and MRI follow-up study
    Sanna Hagman, Minna Raunio, Maija Elina Rossi, Prasun Dastidar, Irina Elovaara · 2011 · Journal of Neuroimmunology
  65. The diagnosis of multiple sclerosis and the clinical subtypes
    Barrie J. Hurwitz · 2009 · Annals of Indian Academy of Neurology
  66. Initial Evaluations for Multiple Sclerosis in a University Multiple Sclerosis Center: Outcomes and Role of Magnetic Resonance Imaging in Referral
    Carmosino, Mario J., Brousseau, Kristin M., Arciniegas, David B., Corboy, John R. · 2005 · Archives of Neurology
  67. Outcome Measures in Relapsing-Remitting Multiple Sclerosis: Capturing Disability and Disease Progression in Clinical Trials
    Amy M. Lavery, Leonard H. Verhey, Amy Tara Waldman · 2014 · Multiple Sclerosis International
  68. Conventional MRI in Multiple Sclerosis
    Massimo Filippi, Maria Assunta Rocca · 2007 · Journal of Neuroimaging
  69. Clinical characteristics and long term prognosis in early onset multiple sclerosis
    Olivier Deryck, Piet Ketelaer, B. Dubois · 2006 · Journal of Neurology
  70. The optic nerve sheath on MRI in acute optic neuritis
    Simon J. Hickman, Katherine Miszkiel, Gordon Terence Plant, David H. Miller · 2005 · Neuroradiology
  71. Longitudinal MR Imaging of Iron in Multiple Sclerosis: An Imaging Marker of Disease
    Andrew J. L. Walsh, Gregg Blevins, Robert Marc Lebel, Peter Seres, Derek J. Emery, Alan H. Wilman · 2013 · Radiology
  72. The neuro-ophthalmology of multiple sclerosis
    Elliot M. Frohman, Teresa C. Frohman, David Samuel Zee, Roderick W. McColl, Steven L. Galetta · 2005 · American Journal of Ophthalmology
  73. Antibody responses against galactocerebroside are potential stage-specific biomarkers in multiple sclerosis
    Til Menge, Patrice H. Lalive, H.‐Christian von Büdingen, Bruce Cree, Stephen L. Hauser, Claude P. Genain · 2005 · Journal of Allergy and Clinical Immunology
  74. EFNS guidelines on the use of neuroimaging in the management of multiple sclerosis
    Massimo Filippi, Maria Assunta Rocca, Douglas Lorne Arnold, Rohit Bakshi, Frederik Barkhof, Nicola De Stefano, Franz Fazekas, Elliot M. Frohman, Jerry S. Wolinsky · 2006 · European Journal of Neurology
  75. Characteristics of multiple sclerosis at onset and delay of diagnosis and treatment in Spain (The Novo Study)
    The Novo Group, Fernández, O., Fernández, V., Arbizu, T., Izquierdo, G., Bosca, I., Arroyo, R., García Merino, J. A., de Ramón, E. · 2010 · Journal of Neurology
  76. A three-year, multi-parametric MRI study in patients at presentation with CIS
    M. Rocca, F. Agosta, M. Sormani, K. Fernando, M. Tintoré, T. Korteweg, Paola Tortorella, David H. Miller, Alan J. Thompson, À. Rovira et al. · 2008 · Journal of Neurology
  77. Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing–remitting multiple sclerosis: subgroup analyses of the DEFINE study
    Amit Bar‐Or, Ralf Gold, Ludwig Kappos, Douglas Lorne Arnold, Gavin Giovannoni, Krzysztof W. Selmaj, John T. O'Gorman, Monica Stephan, Katherine T. Dawson · 2013 · Journal of Neurology
  78. MRI as a marker for disease heterogeneity in multiple sclerosis
    Bibiana Bielekova, Nadja Kadom, Elizabeth Fisher, Neal O. Jeffries, Joan M. Ohayon, Nancy D. Richert, T. Howard, Craig N. Bash, Joseph Alan Frank, L. Stone et al. · 2005 · Neurology
  79. Voluntary wheel running delays disease onset and reduces pain hypersensitivity in early experimental autoimmune encephalomyelitis (EAE)
    Curtis A. Benson, John W. Paylor, Gustavo Tenorio, Ian Robert Winship, Glen B. Baker, Bradley J. Kerr · 2015 · Experimental Neurology
  80. Multiple Sclerosis and Other Inflammatory Demyelinating Diseases of the Central Nervous System
    FRED D. LUBLIN, Aaron Miller · 2008 · Elsevier eBooks
  81. A Deep Learning Approach to Predicting Disease Progression in Multiple Sclerosis Using Magnetic Resonance Imaging
    Loredana Storelli, Matteo Azzimonti, Mor Gueye, Carmen Vizzino, Paolo Preziosa, Gioachino Tedeschi, Nicola De Stefano, Patrizia Pantano, Massimo Filippi, Maria Assunta Rocca · 2022 · Investigative Radiology
  82. Differential diagnosis and evaluation in pediatric multiple sclerosis
    Jin S. Hahn, Daniela Pohl, Mary R. Rensel, Sanjai D. Rao · 2007 · Neurology
  83. Cerebrospinal fluid oligoclonal IgM bands predict early conversion to clinically definite multiple sclerosis in patients with Clinically Isolated Syndrome
    Diana Ferraro, Anna Maria Simone, Roberta Bedin, Veronica Galli, Francesca Vitetta, Lucia Federzoni, Roberto D’Amico, Elisa Merelli, Paolo Nichelli, Patrizia Sola · 2013 · Journal of Neuroimmunology
  84. Peripheral blood biomarkers in multiple sclerosis
    Antonella D’Ambrosio, Simona Pontecorvo, Tania Colasanti, Silvia Zamboni, Ada Francia, Paola Margutti · 2015 · Autoimmunity Reviews
  85. A 6‐year clinical and MRI follow‐up study of patients with relapsing–remitting multiple sclerosis treated with Interferon‐beta
    Andrea Paolillo, Carlo Pozzilli, Elisabetta Giugni, V Tomassini, Claudio Gasperini, Marco Fiorelli, Caterina Mainero, Mark A. Horsfield, Simona Galgani, Stefano Bastianello et al. · 2002 · European Journal of Neurology
  86. MRI features of pediatric multiple sclerosis
    Brenda Banwell, Manohar M. Shroff, Jayne Ness, Douglas Jeffery, Steven Schwid, Bianca Weinstock‐Guttman · 2007 · Neurology
  87. Early clinical markers of aggressive multiple sclerosis
    Charles Benjamin Malpas, Ali Manouchehrinia, Sifat Sharmin, Izanne Roos, Dana Horáková, Eva Havrdová, María Trojano, Guillermo Izquierdo, Sara Eichau, Roberto Bergamaschi et al. · 2020 · Brain
  88. Spinal cord MRI in clinically isolated optic neuritis
    Catherine M. Dalton · 2003 · Journal of Neurology Neurosurgery & Psychiatry
  89. Effect of BG-12 on contrast-enhanced lesions in patients with relapsing– remitting multiple sclerosis: subgroup analyses from the phase 2b study
    Ludwig Kappos, Ralf Gold, David H. Miller, David G. MacManus, Eva Havrdová, Volker Limmroth, Chris H. Polman, Klaus Schmierer, Tarek Ahmed Yousry, Mefkûre Eraksoy et al. · 2011 · Multiple Sclerosis Journal
  90. The Clinical Epidemiology of Multiple Sclerosis
    Christian Confavreux, Sandra Vukusic · 2008 · Neuroimaging Clinics of North America
  91. Effects of delayed-release dimethyl fumarate on MRI measures in the phase 3 CONFIRM study
    David H. Miller, Robert J. Fox, J. Theodore Phillips, Michael Hutchinson, Eva Havrdová, Mariko Kita, Claudia A. M. Gandini Wheeler‐Kingshott, Daniel J. Tozer, David G. MacManus, Tarek Ahmed Yousry et al. · 2015 · Neurology
  92. Efficacy and safety of delayed-release dimethyl fumarate in patients newly diagnosed with relapsing–remitting multiple sclerosis (RRMS)
    Ralf Gold, Gavin Giovannoni, J. Theodore Phillips, Robert James Fox, Annie Zhang, Leslie A. Meltzer, Nuwan Kurukulasuriya · 2014 · Multiple Sclerosis Journal
  93. Cell therapy for multiple sclerosis: an evolving concept with implications for other neurodegenerative diseases
    Claire M Rice, Kevin C. Kemp, Alastair Wilkins, Neil J. Scolding · 2013 · The Lancet
  94. Olfactory bulb volume and olfactory function in patients with multiple sclerosis
    Oender Goektas, Felix Schmidt, Georg Böhner, Katharina Erb, Lutz Lüdemann, Sarah Bettina Dahlslett, Lutz Harms, Franca Fleiner · 2011 · Rhinology Journal
  95. MRI outcomes with cladribine tablets for multiple sclerosis in the CLARITY study
    Gıancarlo Comı, Stuart D. Cook, Gavin Giovannoni, Kottil W Rammohan, Peter Rieckmann, Per Soelberg Sørensen, Patrick Vermersch, Anthony Hamlett, Vissia Viglietta, Steven J. Greenberg · 2012 · Journal of Neurology
  96. Do multimodal evoked potentials add information to MRI in clinically isolated syndromes?
    Raul Pelayo, Xavier Montalbán, Teresa Minoves, Dulce Moncho, Jordi Río, Carlos Nos, Carmen Tur, Joaquín Castilló, Alejandro Horga, Manuel Comabella et al. · 2009 · Multiple Sclerosis Journal
  97. Brain atrophy and lesion load are related to CSF lipid-specific IgM oligoclonal bands in clinically isolated syndromes
    María José Magraner, Isabel Boscá, María Simó, Gracián García‐Martí, Ángel Alberich‐Bayarri, Francisco Coret, Jose Carlos Alvarez-Cermeño, Luis Martí‐Bonmatí, Luisa María Villar, Bonaventura Casanova · 2011 · Neuroradiology
  98. Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS
    Valentina Tomassini, Laura De Giglio, Markus Reindl, Pierluigi Russo, Isabella Ferdinanda Pestalozza, Patrizià Pantano, Thomas Berger, Carlo Pozzilli · 2007 · Multiple Sclerosis Journal
  99. Early MRI in optic neuritis: the risk for clinically definite multiple sclerosis
    Josephine K. Swanton, Kryshani Fernando, Catherine M. Dalton, Katherine Miszkiel, Daniel R. Altmann, Gordon Terence Plant, Alan J. Thompson, DH Miller · 2010 · Multiple Sclerosis Journal
  100. Multiple sclerosis
    Elliot M. Frohman · 2003 · Medical Clinics of North America